PANLAR consensus statement on Biosimilars

By : Global Rheumatology by PANLAR
04 June, 2019
Vistas 334Vistas


This is an open-access article distributed by the terms of the Creative Common Attribution License (CC-BY NC-4). The use, distribution or reproduction in other forms is permitted, provided the original author(a) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with this terms.



Detalle de Infografía:

The Pan-American League of Associations for Rheumatology (PANLAR) has stated its position regarding biosimilars. This infographic is based on the PANLAR document published on the Clinical Rheumatology journal. The recommendations are necessary so that the use of biosimilars may be done in a safe environment for patients and that also provide peace of mind to the physicians in all the countries of America.


More infographics

enviar Envía un artículo